Skip to main content

Advertisement

SpringerLink
Log in

Management of oesophageal cancer

  • Review Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Oesophageal cancer is a disease of dismal prognosis. There are variations of epidemiology among different ethnic groups and geographic regions. India is a country with high incidence. This can be attributed to the interplay between environmental, dietary factors and life-style of the population of the country. Optimal therapeutic strategy for patients with oesophageal cancer demands individual consideration.

Majority of oesophageal cancer patients present at an advanced stage of disease. Screening programmes or strategies aiming at early diagnosis can improve the prognosis; unfortunately this is not cost-effective except in very high incidence areas. Accurate staging can help select the most appropriate treatments, such as excluding those patients with metastatic disease who are unlikely to benefit from surgery, and treating very early lesions with endoscopic means. When surgery is indicated, treating patient in a high-volume centre can improve the outcome and minimise complications. Although surgical resection remains the main treatment modality, long-term prognosis after surgical resection alone has been suboptimal except in those with early disease. Multidisciplinary approaches including chemotherapy and radiotherapy with or without surgery are increasingly employed for patients with advanced disease. Collaboration among surgeons, clinical oncologists, radiologists and physicians is of utmost importance to achieve the best results. Treatment for patients should be individualised to enhance outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Gupta NM, Jindal R, Prakash O, Gupta R, Bhasin DK (2001) Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today 31:400–404

    Article  CAS  PubMed  Google Scholar 

  3. Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049–2053

    Article  CAS  PubMed  Google Scholar 

  4. Law S, Wong J (2002) Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region. J Gastroenterol Hepatol 17:374–381

    Article  PubMed  Google Scholar 

  5. Peters JH, Hagen JA, DeMeester SR (2004) Barrett’s esophagus. J Gastrointest Surg 8:1–17

    Article  PubMed  Google Scholar 

  6. Graham DY (2003) The changing epidemiology of GERD: Geography and Helicobacter pylori. Am J Gastroenterol 98:1462–1470

    Article  PubMed  Google Scholar 

  7. Cherian JV, Sivaraman R, Muthusamy AK, Jayanthi V (2007) Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center. J Gastrointestin Liver Dis 16:245–249

    PubMed  Google Scholar 

  8. Li L, Lu F, Zhang S (1996) Analysis of cancer modality and distribution in China from year 1990 through 1992- an epidemiologic study. Zhonghua Zhong Liu Za Zhi 18:403–407

    CAS  PubMed  Google Scholar 

  9. He YT, Hou J, Qiao CY, et al. (2003) An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. World J Gastroenterol 9:209–213

    PubMed  Google Scholar 

  10. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS (1994) p53 tumour suppressor gene mutation in early esophageal precancerous lesions and carcinoma among highrisk populations in Henan, China. Cancer Res 54:4342–4346

    CAS  PubMed  Google Scholar 

  11. Li MH, Li P, Li PJ (1980) Recent progress in research on esophageal cancer in China. Adv Cancer Res 33:173–249

    Article  CAS  PubMed  Google Scholar 

  12. Phukan RK, Ali MS, Chetia CK, Mahanta J (2001) Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br J Cancer 85:661–667

    Article  CAS  PubMed  Google Scholar 

  13. Khuroo MS, Zargar SA, Mahajan R, Banday MA (1992) High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33:11–15

    Article  CAS  PubMed  Google Scholar 

  14. Lee CH, Lee JM, Wu DC, et al. (2005) Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 113:475–482

    Article  CAS  PubMed  Google Scholar 

  15. Murtaza I, Mushtaq D, Margoob MA, et al. (2006) A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 12:4033–4037

    CAS  PubMed  Google Scholar 

  16. Chitra S, Ashok L, Anand L, Srinivasan V, Jayanthi V (2004) Risk factors for esophageal cancer in Coimbatore, southern India: a hospital-based case-control study. Indian J Gastroenterol 23:19–21

    CAS  PubMed  Google Scholar 

  17. Dawsey SM, Shen Q, Nieberg RK, et al. (1997) Studies of esophageal balloon cytology in Linxian, China. Cancer Epidemiol Biomarkers Prev 6:121–130

    CAS  PubMed  Google Scholar 

  18. Nabeya K, Hanaoka T, Onozawa K, Ri S, Nyumura T, Kaku C (1990) Early diagnosis of esophageal cancer. Hepatogastroenterology 37:368–370

    CAS  PubMed  Google Scholar 

  19. Wang GQ, Jiao GG, Chang FB, et al. (2004) Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 77:1740–1744

    Article  PubMed  Google Scholar 

  20. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR (1994) Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108: 813–821

    CAS  PubMed  Google Scholar 

  21. American Joint Committee on Cancer (2009) Esophagus. In: AJCC Cancer Staging Manual. Springer Verlag, New York

    Google Scholar 

  22. Rosch T (1995) Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 5:537–547

    CAS  PubMed  Google Scholar 

  23. Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH (1999) Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 67:319–321

    Article  CAS  PubMed  Google Scholar 

  24. Luketich JD, Schauer PR, Melttumourr CC, et al. (1997) Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64:765–769

    Article  CAS  PubMed  Google Scholar 

  25. Flamen P, Lerut A, Van Cutsem E, et al. (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18:3202–3210

    CAS  PubMed  Google Scholar 

  26. Lerut T, Flamen P, Ectors N, et al. (2000) Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232:743–752

    Article  CAS  PubMed  Google Scholar 

  27. Luketich JD, Friedman DM, Weigel TL, et al. (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 68:1133–1136

    Article  CAS  PubMed  Google Scholar 

  28. Swisher SG, Maish M, Erasmus JJ, et al. (2004) Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78:1152–1160

    Article  PubMed  Google Scholar 

  29. Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67:381–390

    Article  CAS  PubMed  Google Scholar 

  30. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77:845–857

    Article  CAS  PubMed  Google Scholar 

  31. Birkmeyer JD, Siewers AE, Finlayson EV, et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137

    Article  PubMed  Google Scholar 

  32. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117–2127

    Article  CAS  PubMed  Google Scholar 

  33. Law S, Kwong DL, Kwok KF, et al. (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238:339–347

    PubMed  Google Scholar 

  34. Altorki N, Kent M, Ferrara C, Port J (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177–183

    Article  PubMed  Google Scholar 

  35. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232

    Article  CAS  PubMed  Google Scholar 

  36. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U (2001) Histologic tumour type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234:360–367

    Article  CAS  PubMed  Google Scholar 

  37. Wouters MW, Karim-Kos HE, le Cessie S, et al. (2009) Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol 16:1789-1798

    Google Scholar 

  38. Lagarde SM, Maris AK, de Castro SM, Busch OR, Obertop H, van Lanschot JJ (2007) Evaluation of O-POSSUM in predicting in-hospital mortality after resection for oesophageal cancer. Br J Surg 94:1521–1526

    Article  CAS  PubMed  Google Scholar 

  39. Law SY, Fok M, Wong J (1994) Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 18:339–346

    Article  CAS  PubMed  Google Scholar 

  40. Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240:791–800

    Article  PubMed  Google Scholar 

  41. Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85:840–844

    Article  CAS  PubMed  Google Scholar 

  42. Orringer MB, Marshall B, Iannettoni MD (1999) Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230:392–400

    Article  CAS  PubMed  Google Scholar 

  43. Katariya K, Harvey JC, Pina E, Beattie EJ (1994) Complications of transhiatal esophagectomy. J Surg Oncol 57:157–163

    Article  CAS  PubMed  Google Scholar 

  44. Omloo JM, Lagarde SM, Hulscher JB, et al. (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomised clinical trial. Ann Surg 246:992–1000

    Article  PubMed  Google Scholar 

  45. Cuschieri A, Shimi S, Banting S (1992) Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37:7–11

    CAS  PubMed  Google Scholar 

  46. Qureshi I, Nason KS, Luketich JD (2008) Is minimally invasive esophagectomy indicated for cancer? Expert Rev Anticancer Ther 8:1449–1460

    Article  PubMed  Google Scholar 

  47. Law SY, Fok M, Wei WI, et al. (2000) Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg 70:418–422

    Article  CAS  PubMed  Google Scholar 

  48. Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H (2003) A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90:108–113

    Article  CAS  PubMed  Google Scholar 

  49. Smithers BM, Gotley DC, McEwan D, Martin I, Bessell J, Doyle L (2001) Thoracoscopic mobilization of the esophagus. A 6 year experience. Surg Endosc 15:176–182

    Article  CAS  PubMed  Google Scholar 

  50. Law S, Fok M, Chu KM, Wong J (1997) Thoracoscopic esophagectomy for esophageal cancer. Surgery 122:8–14

    Article  CAS  PubMed  Google Scholar 

  51. Osugi H, Takemura M, Higashino M, et al. (2003) Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 17: 515–519

    Article  CAS  PubMed  Google Scholar 

  52. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220:364–372

    Article  CAS  PubMed  Google Scholar 

  53. Peyre CG, Hagen JA, DeMeester SR, et al. (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–556

    Article  PubMed  Google Scholar 

  54. Rizk NP, Ishwaran H, Rice T, Chen LQ, Schipper P et al. (2009) Optimum lymphadenectomy for esophageal cancer. Ann Surg (In-press)

  55. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359(9319): 1727–1733

    Article  Google Scholar 

  56. Petrasch S, Welt A, Reinacher A, Graeven U, Konig M, Schmiegel W (1998) Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer. Br J Cancer 78:511–514

    CAS  PubMed  Google Scholar 

  57. Kok TC, Kerfhofs L, et al. (1998) Biweekly administration of cisplatin and increasing doses of paclitaxel in patients with advanced esophageal cancer. Proc Am Soc Clin Oncol 17 (Abstract 997)

  58. Herskovic A, Martz K, al-Sarraf M, et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598

    Article  CAS  PubMed  Google Scholar 

  59. Cooper JS, Guo MD, Herskovic A, et al. (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomised trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623–1627

    Article  CAS  PubMed  Google Scholar 

  60. Law S, Wong J (2005) Current management of esophageal cancer. J Gastrointest Surg 9:291–310

    Article  PubMed  Google Scholar 

  61. Baron TH (2001) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681–1687

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China

    Daniel K. H. Tong & Simon Law

Authors
  1. Daniel K. H. Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon Law
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Law.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tong, D.K.H., Law, S. Management of oesophageal cancer. Indian J Surg 71, 317–325 (2009). https://doi.org/10.1007/s12262-009-0087-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-009-0087-3

Keywords

Search

Navigation